Skip to content
★ Sign in to follow
MD

Mark D. Angelino

Executive
Generation Bio Co.
Total declarations
9
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€356k

Latest filing published 20 Jan 2021 for Generation Bio Co., €28k.

Filing timeline

BuySale
Mark D. Angelino

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Mark D. Angelino: trading record in brief

Mark D. Angelino is a declared insider of Generation Bio Co., with filings sourced from SEC (Form 4). We count 9 filings; the first trade dates from 14 August 2020 and the latest from 15 January 2021.

Sales make up the whole of the open-market record (6 sales, €356k). The rest of the record consists of 3 option exercises. 2021 to date brings no purchases and 4 sales.

On 20 January 2021 came the latest disclosure, an open-market sale for €17k in Generation Bio Co. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Mark D. Angelino

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ◇
    CHIEF OPERATING OFFICERExecutivesGeneration Bio Co.
    34,425 USD12SEC
    7,500 shares@ US$4.596.5% of flowCommon StockSEC:0001415889-21-000350:0
  • ▼
    CHIEF OPERATING OFFICERExecutivesGeneration Bio Co.
    113,015 USD31SEC
    3,500 shares@ US$32.2921.3% of flowCommon StockSEC:0001415889-21-000350:1
  • ▼
    CHIEF OPERATING OFFICERExecutivesGeneration Bio Co.
    96,222 USD31SEC
    2,900 shares@ US$33.1818.2% of flowCommon StockSEC:0001415889-21-000350:2
  • ▼
    CHIEF OPERATING OFFICERExecutivesGeneration Bio Co.
    17,060 USD29SEC
    500 shares@ US$34.123.2% of flowCommon StockSEC:0001415889-21-000350:3
  • ▼
    CHIEF OPERATING OFFICERExecutivesGeneration Bio Co.
    20,976 USD29SEC
    600 shares@ US$34.964.0% of flowCommon StockSEC:0001415889-21-000350:4
  • ◇
    Chief Operating OfficerExecutivesGeneration Bio Co.
    24,332 USD12SEC
    5,301 shares@ US$4.599.8% of flowCommon StockSEC:0000899243-20-034283:0
  • ▼
    Chief Operating OfficerExecutivesGeneration Bio Co.
    153,463 USD29SEC
    4,401 shares@ US$34.8761.8% of flowCommon StockSEC:0000899243-20-034283:1
  • ▼
    Chief Operating OfficerExecutivesGeneration Bio Co.
    31,968 USD24SEC
    900 shares@ US$35.5212.9% of flowCommon StockSEC:0000899243-20-034283:2
  • ◇
    Chief Operating OfficerExecutivesGeneration Bio Co.
    37,536 USD13SEC
    62,560 shares@ US$0.6015.5% of flowCommon StockSEC:0000899243-20-022713:0

9 of 9 declarations